Assembly biosciences, inc. (ASMB)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
Collaboration revenue

15,963

14,804

9,019

0

-

-

-

-

-

-

-

Collaboration revenue

-

-

-

-

0

-

-

-

-

-

-

Operating expenses:
Research and development

85,757

72,741

44,225

33,093

18,357

10,716

15,029

19,514

25,277

1,850

2,942

General and administrative

32,919

34,798

17,021

12,185

11,297

13,239

4,575

5,341

8,724

2,915

397

Total operating expenses

118,676

107,539

61,246

-

-

-

-

-

-

-

-

Total operating expenses

-

-

-

45,278

29,655

23,956

19,604

-

-

-

-

Loss from operations

-102,713

-92,735

-52,227

-45,278

-29,655

-23,956

-19,604

-24,855

-34,002

-4,766

-3,340

Other income
Interest and other income, net

4,300

3,083

983

1,539

1,228

167

201

-

-

-

-

Other income (expense), net

5

-

-615

-

-

-

-

-

-

-

-

Loss on sale of marketable securities

-

-

-

-1,140

-

-

-

-

-

-

-

Realized loss from marketable securities

-

-

-

-

-27

0

-

-

-

-

-

Beneficial conversion feature

-

-

-

-

-

-

-

0

0

6,001

-

Amortization of debt discount and warrants

-

-

-

-

-

-

-

0

302

2,484

78

Interest expense

-

-

-

-

-

-

-

0

116

2,043

-

Total other income

4,305

3,083

368

399

1,201

167

201

65

-342

-10,524

-1,199

Loss before income taxes

-98,408

-89,652

-51,859

-44,879

-28,453

-23,788

-

-

-

-

-

Income tax benefit

-774

1,099

-9,050

-618

0

0

-

-

-

-

-

Interest income

-

-

-

-

-

-

-

65

76

5

0

Interest Expense

-

-

-

-

-

-

-

-

-

-

1,120

Net loss

-97,634

-90,751

-42,809

-44,261

-28,453

-23,788

-19,403

-24,790

-34,344

-15,290

-4,539

Other comprehensive (loss) income
Unrealized loss recognized in accumulated other comprehensive loss before reclassification, net of tax benefit of $50,664, $31,844, $44,192 and $89,281, respectively

146

45

209

221

-848

0

-

-

-

-

-

Reclassification adjustment of unrealized loss included in net loss, net of tax expense of $56,139, $37,987, $56,139 and $221,358, respectively

-

-

-

-

27

0

-

-

-

-

-

Comprehensive loss

-97,488

-90,706

-42,600

-44,040

-29,275

-23,788

-

-

-

-

-

Net loss per share, basic and diluted

-3.72

-3.98

-2.41

-2.57

-1.81

-3.40

-5.00

-1.94

-3.57

-24.67

-10.02

Weighted average common shares outstanding, basic and diluted

26,258

22,801

17,750

17,226

15,702

6,998

3,878

12,726

9,613

619

445